Transformative Technologies
for the Treatment Continuum

ReShape Lifesciences, Inc. is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. Our portfolio includes the ReShape BalloonTM and ReShape vBlocTM, as well as the ReShape VestTM*, an investigational device, to help treat more patients with obesity.

Obesity Graph

Leading Innovation

The ReShape Gastric Balloon is a non-surgical, non-anatomy altering, non-permanent approach to weight loss for patients with a BMI of 30-40.

ReShape Balloon

  • Non-surgical
  • Non-anatomy altering
  • Non-permanent

vBloc Therapy is a minimally invasive, non-anatomy altering, reversible option for weight loss for patients with a BMI of 35-45.

ReShape vBloc

  • Minimally invasive
  • Non-anatomy altering
  • Reversible

The ReShape Gastric Vest System is an anatomy-friendly, removable weight loss option for patients with a BMI of 35-50.

ReShape Vest*

  • Anatomy friendly
  • No stapling, cutting, or removing the stomach
  • Removable

About ReShape Lifesciences

ReShape Lifesciences is committed to the delivery of safe, effective, and sustainable therapies that address the growing global health crises associated with the increased prevalence of obesity and metabolic diseases, including diabetes and hypertension. We are rapidly advancing our novel technologies to broadly benefit patients, healthcare providers, and stakeholders around the world.

Recent News

*Not available for sale in the United States.